Dosing Underway for Phase 1 Parkinson Trial of GBA1-Targeting Agent GT-02287
- Details
- Written by: Developer SM
- Category: In The News
- Hits: 117
Dosing Underway for Phase 1 Parkinson Trial of GBA1-Targeting Agent GT-02287
NeurologyLive
October 9, 2023
https://www.neurologylive.com/view/dosing-underway-phase-1-parkinson-trial-gba1-targeting-agent-gt-02287